ORIGINAL RESEARCH PAPER ON PROSPECTIVE OBSERVATIONAL STUDY FOR RISK OFPOLYPHARMACY PRESCRIPTION PATTERNS AT TERTIARY CARE HOSPITAl

Abstract

Background: Polypharmacy, the concurrent use of multiple medications, has become a prevalent concern in healthcare systems worldwide. This prospective observational study aimed to assess the relative risk and incidence of polypharmacy while investigating its impact on patient outcomes and exploring strategies for minimizing its irrational use. Forms for complete case reports and informed permission were used in the data gathering procedure. The study had 68 individuals in all, including both males and females. Utilizing statistical tools various parameters were analyzed to evaluate the adverse effects of polypharmacy. Hepatic and renal abnormalities, adverse drug reactions, drug-drug interactions, and demographic factors were meticulously examined. Furthermore, medication adherence, patient history (both medical and social), and co-morbidities were assessed to provide a comprehensive understanding of polypharmacy's implications. By adopting a patient-centered approach, this study sought to improve the quality of life, reduce mortality and morbidity, and minimize irrational medication practices. The findings shed light on the critical role of clinical pharmacokinetic considerations in addressing the challenges associated with polypharmacy. Result: This study emphasizes the demand for efficient methods for controlling and preventing polypharmacy. Through the identification and understanding of associated risks and adverse effects, healthcare professionals can develop new approaches to reduce the prevalence of polypharmacy and enhance patient care. By optimizing medication regimens and fostering individualized treatment plans, healthcare providers can significantly mitigate the potential harm caused by polypharmacy and improve patient outcomes. Conclusion: Addressing the challenges posed by polypharmacy by employing a multidisciplinary approach that encompasses patient education, healthcare provider collaboration, and the development of evidence-based guidelines, can effectively minimize the occurrence of polypharmacy and optimize medication practices.